Hospitals | April 13, 2026
Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
Glenmark's Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg is the authorized generic to Savella Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
